Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 7 | 2024 | 89 | 2.210 |
Why?
|
| Gastric Bypass | 11 | 2023 | 74 | 2.180 |
Why?
|
| Laparoscopy | 15 | 2023 | 385 | 1.830 |
Why?
|
| Hernia, Hiatal | 2 | 2021 | 26 | 1.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2024 | 675 | 1.010 |
Why?
|
| Gastrectomy | 2 | 2024 | 34 | 1.000 |
Why?
|
| Social Class | 1 | 2024 | 123 | 0.910 |
Why?
|
| Insulin Resistance | 7 | 2015 | 403 | 0.800 |
Why?
|
| Herniorrhaphy | 2 | 2021 | 65 | 0.630 |
Why?
|
| Weight Loss | 6 | 2023 | 259 | 0.480 |
Why?
|
| Blood Glucose | 2 | 2015 | 470 | 0.470 |
Why?
|
| Preoperative Care | 1 | 2015 | 174 | 0.450 |
Why?
|
| Obesity | 5 | 2015 | 1189 | 0.390 |
Why?
|
| Pancreatic Neoplasms | 5 | 2001 | 316 | 0.380 |
Why?
|
| Retrospective Studies | 9 | 2024 | 5975 | 0.350 |
Why?
|
| Insulin | 3 | 2011 | 687 | 0.350 |
Why?
|
| Bariatric Surgery | 2 | 2024 | 45 | 0.340 |
Why?
|
| Heart Conduction System | 1 | 2009 | 49 | 0.330 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2007 | 45 | 0.330 |
Why?
|
| Intestinal Obstruction | 1 | 2009 | 47 | 0.320 |
Why?
|
| Heart Rate | 1 | 2009 | 304 | 0.300 |
Why?
|
| Pheochromocytoma | 1 | 2007 | 27 | 0.280 |
Why?
|
| Middle Aged | 16 | 2024 | 16238 | 0.270 |
Why?
|
| Adult | 14 | 2024 | 15735 | 0.260 |
Why?
|
| Adipose Tissue, Brown | 1 | 2007 | 100 | 0.260 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 533 | 0.260 |
Why?
|
| Postoperative Complications | 3 | 2015 | 1130 | 0.260 |
Why?
|
| Peptic Ulcer | 2 | 2024 | 21 | 0.260 |
Why?
|
| Male | 20 | 2024 | 27509 | 0.250 |
Why?
|
| Humans | 30 | 2024 | 59328 | 0.250 |
Why?
|
| Glucose | 2 | 2007 | 444 | 0.250 |
Why?
|
| Homeostasis | 1 | 2007 | 340 | 0.240 |
Why?
|
| Female | 19 | 2024 | 30827 | 0.240 |
Why?
|
| Peptic Ulcer Perforation | 1 | 2024 | 5 | 0.230 |
Why?
|
| Treatment Outcome | 6 | 2024 | 5142 | 0.220 |
Why?
|
| Round Ligaments | 1 | 2023 | 3 | 0.220 |
Why?
|
| Incidence | 2 | 2021 | 1232 | 0.210 |
Why?
|
| Gastroesophageal Reflux | 1 | 2023 | 77 | 0.210 |
Why?
|
| Surgical Mesh | 1 | 2021 | 57 | 0.190 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2000 | 202 | 0.190 |
Why?
|
| Esophagectomy | 1 | 2021 | 44 | 0.180 |
Why?
|
| Recurrence | 2 | 2021 | 576 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2001 | 168 | 0.180 |
Why?
|
| Kupffer Cells | 2 | 2015 | 42 | 0.170 |
Why?
|
| Body Mass Index | 5 | 2011 | 891 | 0.160 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 2323 | 0.160 |
Why?
|
| Aspirin | 1 | 2000 | 186 | 0.150 |
Why?
|
| Adipose Tissue, White | 2 | 2008 | 82 | 0.140 |
Why?
|
| Risk Factors | 2 | 2021 | 4999 | 0.140 |
Why?
|
| Adipose Tissue | 2 | 2010 | 283 | 0.130 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 47 | 0.120 |
Why?
|
| Remission Induction | 1 | 2015 | 137 | 0.120 |
Why?
|
| Helicobacter Infections | 1 | 2015 | 55 | 0.120 |
Why?
|
| Helicobacter pylori | 1 | 2015 | 58 | 0.120 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 97 | 0.120 |
Why?
|
| Splenectomy | 2 | 2004 | 41 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 5 | 2001 | 454 | 0.110 |
Why?
|
| Adenocarcinoma | 3 | 2001 | 322 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2006 | 580 | 0.100 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 40 | 0.090 |
Why?
|
| Subcutaneous Fat | 1 | 2011 | 50 | 0.090 |
Why?
|
| Omentum | 1 | 2010 | 12 | 0.090 |
Why?
|
| Prognosis | 1 | 2015 | 1564 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2000 | 201 | 0.090 |
Why?
|
| Cell Division | 3 | 2001 | 442 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 102 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 138 | 0.090 |
Why?
|
| Laparotomy | 3 | 2024 | 45 | 0.090 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2009 | 39 | 0.080 |
Why?
|
| Sodium Salicylate | 2 | 1999 | 2 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 177 | 0.080 |
Why?
|
| I-kappa B Proteins | 2 | 1999 | 38 | 0.080 |
Why?
|
| Hernia | 1 | 2009 | 15 | 0.080 |
Why?
|
| NF-kappa B | 3 | 2000 | 461 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 1024 | 0.080 |
Why?
|
| Peritoneal Lavage | 1 | 2009 | 4 | 0.080 |
Why?
|
| Sex Factors | 2 | 2009 | 959 | 0.080 |
Why?
|
| Colon, Sigmoid | 1 | 2009 | 10 | 0.080 |
Why?
|
| Diverticulitis | 1 | 2009 | 27 | 0.080 |
Why?
|
| Gastroplasty | 1 | 2008 | 14 | 0.080 |
Why?
|
| Linear Models | 1 | 2009 | 419 | 0.080 |
Why?
|
| Wounds, Stab | 1 | 2008 | 13 | 0.080 |
Why?
|
| Age Factors | 2 | 2009 | 1518 | 0.070 |
Why?
|
| Abdominal Injuries | 1 | 2008 | 31 | 0.070 |
Why?
|
| Luminescent Measurements | 1 | 2007 | 37 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 149 | 0.070 |
Why?
|
| Immunoassay | 1 | 2007 | 51 | 0.070 |
Why?
|
| Radiography | 1 | 2009 | 505 | 0.070 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2008 | 106 | 0.070 |
Why?
|
| RNA Interference | 2 | 2008 | 589 | 0.070 |
Why?
|
| Blotting, Western | 4 | 2000 | 595 | 0.070 |
Why?
|
| Triglycerides | 1 | 2008 | 242 | 0.070 |
Why?
|
| Radiographic Image Enhancement | 1 | 2007 | 98 | 0.070 |
Why?
|
| Length of Stay | 3 | 2024 | 765 | 0.070 |
Why?
|
| Nephrectomy | 1 | 2006 | 49 | 0.060 |
Why?
|
| Macrophages, Peritoneal | 1 | 2006 | 73 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2007 | 190 | 0.060 |
Why?
|
| Comorbidity | 1 | 2009 | 1086 | 0.060 |
Why?
|
| Splenomegaly | 1 | 2004 | 22 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2000 | 454 | 0.060 |
Why?
|
| Splenic Diseases | 1 | 2004 | 14 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2007 | 550 | 0.060 |
Why?
|
| Contrast Media | 1 | 2007 | 408 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 895 | 0.060 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2004 | 21 | 0.060 |
Why?
|
| Apoptosis | 2 | 1999 | 1038 | 0.060 |
Why?
|
| Inflammation | 1 | 2010 | 1101 | 0.050 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2003 | 5 | 0.050 |
Why?
|
| G1 Phase | 2 | 2001 | 53 | 0.050 |
Why?
|
| Adrenalectomy | 1 | 2003 | 24 | 0.050 |
Why?
|
| Macrophages | 2 | 1999 | 1006 | 0.050 |
Why?
|
| Massachusetts | 1 | 2009 | 2083 | 0.050 |
Why?
|
| S Phase | 2 | 2001 | 76 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2003 | 99 | 0.050 |
Why?
|
| Cell Separation | 2 | 2000 | 149 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2003 | 126 | 0.050 |
Why?
|
| Spleen | 1 | 2004 | 485 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2009 | 1907 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2009 | 3095 | 0.050 |
Why?
|
| Immunophilins | 1 | 2001 | 1 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2001 | 8 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2008 | 710 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2001 | 671 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2001 | 47 | 0.050 |
Why?
|
| Chromones | 1 | 2000 | 17 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2000 | 119 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2000 | 21 | 0.040 |
Why?
|
| Morpholines | 1 | 2000 | 86 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2024 | 446 | 0.040 |
Why?
|
| Flavonoids | 1 | 2000 | 73 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 1455 | 0.040 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1999 | 21 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 29 | 0.040 |
Why?
|
| Ubiquitins | 1 | 1999 | 41 | 0.040 |
Why?
|
| Phosphorylation | 4 | 2006 | 861 | 0.040 |
Why?
|
| Young Adult | 1 | 2009 | 4320 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 1999 | 77 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 1999 | 90 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1999 | 27 | 0.040 |
Why?
|
| Ischemia | 1 | 2000 | 190 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2000 | 189 | 0.040 |
Why?
|
| Endotoxins | 1 | 1999 | 79 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2003 | 677 | 0.040 |
Why?
|
| Lipopolysaccharides | 4 | 2006 | 645 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2000 | 379 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 2034 | 0.040 |
Why?
|
| Aged | 4 | 2009 | 13293 | 0.040 |
Why?
|
| Adipocytes | 2 | 2010 | 252 | 0.030 |
Why?
|
| Animals | 7 | 2015 | 19613 | 0.030 |
Why?
|
| Liver | 1 | 2000 | 785 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2015 | 79 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 148 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2015 | 36 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2015 | 98 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 3189 | 0.030 |
Why?
|
| Stomach | 1 | 2015 | 84 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 475 | 0.030 |
Why?
|
| Fatty Liver | 1 | 2015 | 97 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2008 | 522 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 373 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 200 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2006 | 185 | 0.030 |
Why?
|
| Mice | 3 | 2015 | 10258 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 377 | 0.030 |
Why?
|
| Swine | 2 | 2006 | 338 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2006 | 309 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2008 | 1470 | 0.020 |
Why?
|
| Mutation | 1 | 2000 | 2427 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2006 | 2103 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 307 | 0.020 |
Why?
|
| Angiopoietins | 1 | 2011 | 5 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2001 | 2890 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 906 | 0.020 |
Why?
|
| Chemokines | 1 | 2010 | 94 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 1999 | 26 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2000 | 353 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 851 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 500 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 569 | 0.020 |
Why?
|
| Perilipin-1 | 1 | 2008 | 12 | 0.020 |
Why?
|
| Demography | 1 | 2009 | 178 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 83 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2008 | 187 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2008 | 51 | 0.020 |
Why?
|
| Lipolysis | 1 | 2008 | 47 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2008 | 71 | 0.020 |
Why?
|
| Reoperation | 1 | 2008 | 249 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 808 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2008 | 216 | 0.020 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2006 | 56 | 0.020 |
Why?
|
| RNA | 1 | 2010 | 404 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2006 | 50 | 0.020 |
Why?
|
| Rats | 2 | 2000 | 1907 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2006 | 83 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2006 | 21 | 0.020 |
Why?
|
| Abdomen | 1 | 2006 | 89 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2006 | 363 | 0.020 |
Why?
|
| Time Factors | 2 | 2006 | 3567 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 1093 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 1582 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1977 | 0.010 |
Why?
|
| Palpation | 1 | 2004 | 9 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 2004 | 22 | 0.010 |
Why?
|
| Hand | 1 | 2004 | 65 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 416 | 0.010 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2004 | 85 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2004 | 53 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 1999 | 1128 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 2437 | 0.010 |
Why?
|
| Proteins | 1 | 2008 | 742 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 759 | 0.010 |
Why?
|
| Mitogens | 1 | 2001 | 10 | 0.010 |
Why?
|
| Fetal Proteins | 1 | 2001 | 11 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2001 | 31 | 0.010 |
Why?
|
| CDC2 Protein Kinase | 1 | 2001 | 33 | 0.010 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2000 | 13 | 0.010 |
Why?
|
| Sirolimus | 1 | 2001 | 73 | 0.010 |
Why?
|
| Bile | 1 | 2000 | 19 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 2000 | 18 | 0.010 |
Why?
|
| Reperfusion | 1 | 2000 | 37 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2001 | 115 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2000 | 51 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2001 | 139 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 1537 | 0.010 |
Why?
|
| Ibuprofen | 1 | 1999 | 19 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 35 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 315 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1999 | 45 | 0.010 |
Why?
|
| Platelet Activating Factor | 1 | 1999 | 4 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 1999 | 124 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1999 | 28 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 125 | 0.010 |
Why?
|
| Cell Survival | 1 | 1999 | 553 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1999 | 603 | 0.010 |
Why?
|
| Cell Line | 1 | 1999 | 2014 | 0.010 |
Why?
|